Veterinarians occasionally use compounded preparations to meet a specific patient’s medical need. The purpose of this brochure, created jointly by the Animal Health Institute (AHI), the American Veterinary Distributors Association (AVDA), and the American Veterinary Medical Association (AVMA), is to explain the Food and Drug Administration (FDA) requirements for compounding preparations for veterinary use and the distinction between drug products approved by the US FDA and compounded preparations.
Related Resources
Position on the Use of Medroxyprogesterone Acetate in Competition Horses
Medroxyprogesterone acetate (MPA) is a synthetic progestin hormone administered to mares off-label…
Breeding Terminology
In providing written reports to interested parties, the AAEP encourages all equine…
Position on the Use of Horses in Urban Environments
The AAEP supports the use of horses and other equids in urban…